¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Disease, Gaucher type 1"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
  • minimal change disease
    ¹Ì¼¼º¯È­º´
  • malabsorption disease
    Èí¼öÀå¾Öº´
  • mixed connective tissue disease
    È¥ÇÕ°áÇÕÁ¶Á÷º´
  • molecular disease
    ºÐÀÚº´
  • Monge disease
    ¸ùÇ캴
  • motor neuron disease
    ¿îµ¿½Å°æ¼¼Æ÷º´, ¿îµ¿½Å°æ¿øº´
  • mountain disease
    °í»êº´
  • moyamoya disease
    ¸ð¾ß¸ð¾ßº´
  • muscle disease
    ±ÙÀ°º´
  • mycobacterial disease
    Ç×»ê±Õº´, ¹ÌÄÚ¹ÚÅ׸®¾Æº´
  • mycoplasma disease
    ¹ÌÄÚÇö󽺸¶º´
  • maple syrup urine disease
    ´Üdz½Ã·´´¢º´
  • marble bone disease
    ´ë¸®¼®º´, °ñÈ­¼®º´
  • Marburg disease
    ¸¶¸£ºÎ¸£Å©º´
  • Marburg virus disease
    ¸¶¸£ºÎ¸£Å©¹ÙÀÌ·¯½ºº´
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
  • microdrepanocytic disease
    ÀÛÀº³´ÀûÇ÷±¸º´
  • miner¡¯s disease
    ±¤ºÎº´
  • minimal change disease
    ÃÖ¼Òº¯È­ÄáÆÏº´Áõ
  • mixed connective tissue disease
    È¥ÇÕ°áÇÕÁ¶Á÷º´, ½Â¸ðÆÇ¸·º´
  • molecular disease
    ºÐÀÚº´
  • motor neuron disease
    ¿îµ¿½Å°æ¼¼Æ÷º´
  • mountain disease
    °í»êº´
  • moyamoya disease
    ¸ð¾ß¸ð¾ßº´
  • muscle disease
    ±ÙÀ°º´
  • mycobacterial disease
    Ç×»ê±Õº´
  • mycoplasma disease
    ¹ÌÄÚÇö󽺸¶º´
  • neoplastic disease
    Á¾¾çº´, ½Å»ý¹°º´
  • nervous disease
    ½Å°æº´
  • neurohypophysial disease
    ½Å°æ³úÇϼöüº´
  • neuromuscular disease
    ½Å°æ±ÙÀ°º´
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
  • Wernicke s disease
    º£¸£´ÏÄɺ´.
  • Wernickes disease
    º£¸£´ÏÄɺ´.
  • Wilsons disease
    Àª½¼º´
  • accumulation disease
    ÃàÀûº´(õëîÝÜ»).
  • acquired cystic disease of the kidney
    ÈÄõ¼º ½Å³¶Æ÷Áúȯ
  • acquired disease
    ÈÄõ¼º Áúº´(¡­òðÜ»).
  • acquired heart disease =AHD
    ÈÄõ¼º ½ÉÁúȯ(¡­ãýòðü´).
  • acute demyelinating disease
    ±Þ¼º Å»¼öÃʼº Áúȯ(¡­÷­âÐõ¦àõòðü´).
  • acute febrile neutrophilic dermatosis ; Sweet disease
    ±Þ¼º À¯¿­ È£Áß±¸¼º ÇǺÎÁõ.
  • acute febrile neutrophilic dermatosis = Sweet disease
    ±Þ¼º À¯¿­ È£Áß±¸¼º ÇǺÎÁõ
  • acute infectious disease
    ±Þ¼º °¨¿°Áúȯ
  • acute infectious disease =AID
    ±Þ¼º Àü¿°º´(¡­îîæøÜ»).
  • acute respiratory disease =ARD
    ±Þ¼º È£Èí±âº´(¡­û¼ýåÐïÜ»).
  • acute respiratory disease =ARD
    ±Þ¼º È£Èí±âº´(¡­û¼ýåÐïÜ»).
  • addisons disease
    ¾Öµð½¼º´<<ºÎ½Å±â´ÉºÎÀü>>
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
  • alpha chain disease
    ¾ËÆÄ¼âÁúȯ
  • alpha-chain disease
    ¾ËÆÄ¼â Áúȯ(¡­áð òðü´)
  • alports syndrome(disease)
    ¾ËÆ÷Æ® ÁõÈıº(º´)(¡­ñøý¦ÏØ)
  • aluminium dust disease
    ¾Ë·ç¹Ì´½°¡·çº´(ÊÙËÓ).
  • alzheimers disease
    ¾ËÂêÇÏÀ̸Ӻ´(¡­Ü»)
  • amaurotic familial idiocy =Tay-Sachs disease
    °¡Á·¼º Èæ³»Àå ¹éÄ¡(Ê«ðéàõýÙÒ®î¡ÛÜöÁ).
  • amaurotic familial idiocy =Tay-Sachs disease
    °¡Á·¼ºÈæ¾Ï½Ã¹éÄ¡(Ê«ðéàõýÙÒ®î¡ÛÜöÁ).
  • amyloid disease
    ¾Æ¹Ð·ÎÀ̵庴(¡­Ü»).
  • andersen disease
    ¾Ø´õ½¼º´<--Áúȯ>
  • angiospasmodic disease
    Ç÷°ü¿¬Ã༺ Áúȯ.
  • aortic valvular disease
    ´ëµ¿¸ÆÆÇÁúȯ(¡­òðü´).
  • aphthous fever =foot and mouth disease
    ¾ÆÇÁŸ¼º¿­(¡­æð).
  • apocrine miliaria => Fox Fordyce disease
    ¾ÆÆ÷Å©¸° ÇÑÁø
  • arbovirus disease
    ¾Æ¸£º¸¹ÙÀÌ·¯½ºº´(¡­Ü»)
  • arteriosclerotic cardiovascular disease
    µ¿¸Æ°æÈ­¼º ½ÉÇ÷°üº´(¡­ãýúìηܻ).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 17
PVOD pulmonary vascular obstructive disease; pulmonary veno-occlusive disease
RHD radiological health data; relative hepatic dullness; renal hypertensive disease; rheumatic heart dis...
SCD scleroderma; service-connected disability; sickle-cell disease; spinocerebellar degeneration; subacu...
SMCD senile macular choroidal degeneration; systemic mast cell disease; systemic meningococcal disease
URD unspecified respiratory disease; upper respiratory disease
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 17
DTH Delayed Type Hypersensitivity
DTH Delayed type hypersensitivity reaction
DTH Delayed type hypersensitivity response
DTH Delayed type of hypersensitivity
DH Delayed-type hypersensitivity
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • motor system disease
    ¿îµ¿°è Àå¾Ö
  • mountain disease
    °í»êº´, »ê¾Çº´, »ê¸Ö¹Ì
    Àú»ê¼ÒÁõÀ» ÀÏÀ¸Å°±â¿¡´Â ÃæºÐÇÑ °í¼Ò¿¡ ³ëÃâµÊÀ¸·Î½á ÀϾ´Â ÁõÈıºÀ¸·Î¼­, °¨¼ÒµÈ ´ë±â¾Ð°ú ÀÌ¿¡ µû¸£´Â µ¿¸ÆÇ÷ÀÇ »ê¼Ò ÇÔ·® ÀúÇÏÀÇ °á°ú·Î ÀϾ´Ù. ±Þ¼ºÇü
  • Moyamoya disease
    ¸ð¾ß¸ð¾ß º´
    1. ³»°æ µ¿¸Æ ¸»´ÜºÎ¿¡ ÇùÂø, Æó»öÀÇ ¾ç»óÀÌ ³ªÅ¸³ª´Â Áúȯ.Àª¸®½º µ¿¸Æ·û Æó»öÁõ, ³úÀúºÎ ÀÌ»ó Ç÷°ü¸ÁÁõÀ̶ó°íµµ ÇÑ´Ù. µ¹¹ß¼º ³ú Ç÷°ü ºÎÀüÁõ¿¡¼­ º¼ ¼ö Àִµ¥ ³ú ÀúºÎÀÇ Á¤»ó Ç÷°ü ´ë½Å¿¡ ¼Òµ¿¸ÆÀÇ Èñ¹ÌÇÑ ±×¹° ¸ð¾ç
  • mucosal disease
    Á¡¸· º´
  • Mukulicz disease
    ¹«Å¬¸®Âê º´
    ´©¼±°ú Ÿ¾×¼±ÀÌ ÆíÃø¼º ¶Ç´Â ´ëμºÀ¸·Î Á¾Ã¢ÀÌ ¹ß»ýÇÏ´Â ÁúȯÀ¸·Î, ÀÌÇϼ±¿¡¼­ ÁÖ·Î ¹ß»ýµÇ³ª ¸¹Àº ¼ÒŸ¾×¼±µéµµ Á¾Ã¢ÀÌ ³ªÅ¸³ª¸ç ¾Æ¹«·± Áõ»óÀÌ ¾øÀÌ ¼ö°³¿ù ¶Ç´Â ¼ö³â°£ Áö¼ÓµÇ±âµµ ÇÑ´Ù. Ÿ¾×¼± Á¶Á÷¿¡ ¸²ÇÁ±¸ÀÇ Ä§À±À¸·Î Ÿ¾×¼± ½ÇÁú Á¶Á÷ÀÌ À§ÃàµÇ°í ¼Ò½ÇµÇ¸ç µµ°ü »óÇÇÀÇ Áõ½ÄÀ¸·Î °ü°­ÀÌ Çù¼ÒÇØÁö°í µµ°ü »óÇÇ¿Í ±Ù»óÇÇ ¼¼Æ÷ÀÇ Áõ½ÄÀ¸·Î Ç¥ÇDZ٠»óÇǷθ¦ Çü¼ºÇÑ´Ù.
  • mushroom picker's disease
    ¹ö¼¸ ÀÛ¾÷ÀÚ º´
    ³óºÎ Æó¿Í À¯»çÇÑ ¾Ë·¯Áö¼º È£Èí°è ÁúȯÀ¸·Î¼­ ¹ÐÆóµÈ Àå¼Ò¿¡¼­ ¹ö¼¸ »ýÀ°¿ëÀÇ ½âÀº Åðºñ¸¦ Ãë±ÞÇÏ´Â »ç¶÷µé, ƯÈ÷ ¼öÈ® ÈÄ °ÇÁ¶¹°À» Ãë±ÞÇÏ´Â »ç¶÷µé¿¡°Ô¼­ ¹ßº´ÇÑ´Ù.
  • neoplastic disease
    ½Å»ý¹° Áúȯ, Á¾¾ç¼º Áúȯ, ½Å»ý¹°¼º Áúȯ
  • neuronal storage disease
    ½Å°æ ÃàÀûÁõ
  • nevoid disease
    ¸ð¹Ý¾çÁõ
  • Newcastle disease
    ´ºÄ¹½½ º´
    °¡±Ý·ù¸¦ Æ÷ÇÔÇÑ Á¶·ùÀÇ ¹ÙÀÌ·¯½º º´À¸·Î¼­ È£Èí±â ¹× À§Àå ¶Ç´Â Æó·Å ¹× ³ú¿° Áõ»óÀÌ Æ¯Â¡ÀÌ´Ù. ¿µ±¹ÀÇ ´ºÄ¹½½ ºÎ±Ù¿¡¼­ ÃÖÃÊ·Î ¹ß°ßµÇ¾úÀ¸¸ç °¨¿°µÈ Á¶·ù¿ÍÀÇ Á¢ÃËÀ¸·Î »ç¶÷¿¡°Ô ¸Å°³µÈ´Ù.
  • Niemann disease
    ´Ï¸¸ÇÈ Áúȯ
    »ýÈÄ ¸î °³¿ùÂë ÇØ¼­ ¹ßº´Çϴµ¥, ½ÉÇÑ °£ºñ Á¾Ã¢, ºÎÁ¾, º¹¼ö, ÇǺÎÀÇ È²»öÁ¶ µîÀÇ Áõ»óÀ» º¼ ¼ö ÀÖ°í, Á¶Á÷ÇÐÀûÀ¸·Î´Â ¸Á³»°è ¼¼Æ÷°¡ ´Ù·®ÀÇ ¸®Æ÷À̵带 ޽ÄÇÏ¿© ´Ï¸¸-ÇÇÅ© ¼¼Æ÷·Î º¯È­ÇØ °£´Ù.
  • Norrie's disease ¸Á¸· ±âÇü¿¡ ÀÇÇÑ ¾çÂÊ ´«ÀÇ ½Ç¸í, Á¤½Å ¹ß´Þ Áö¿¬, ³­Ã»ÀÌ ³ªÅ¸³ª´Â À¯Àü¼º ÁúȯÀ¸·Î¼­ ¹Ý¼º À¯ÀüÀ¸·Î Àü´ÞµÈ´Ù.

    North America

    ºÏ¹Ì
  • notifiable disease
    ½Å°í ´ë»ó º´
    Àü¿°¼º, ÁßÁõµµ ¹× ºóµµ ¶§¹®¿¡ Áß¾Ó, ÁÖ ¶Ç´Â Áö¹æ °üû¿¡ ¹ß»ý º¸°í¸¦ ¿äÇÏ´Â Áúȯ.
  • obliterative arterial disease
    Æó»ö¼º µ¿¸Æ Áúȯ
  • occupational disease
    Á÷¾÷º´
    1. ¾î¶² ƯÁ¤ Á÷¾÷¿¡ Á¾»çÇÔÀ¸·Î½á ±Ù·Î Á¶°ÇÀÌ ¿øÀÎÀÌ µÇ¾î ÀϾ´Â Áúȯ. ±× Á÷¾÷¿¡ Á¾»çÇϰí ÀÖÀ¸¸é ´©±¸µçÁö ÀÌȯµÉ °¡´É¼ºÀÌ ÀÖ´Â Á¡ÀÌ Æ¯»öÀ̸ç, ÀÛ¾÷ ȯ°æÀÇ ºÒºñ³ª ±Ù·Î °úÁßÀÌ °ãÃļ­ ¸¹Àº °æ¿ì¿¡ ¸¸¼ºÀÇ °æ°ú¸¦ °ÅÃÄ ¹ßº´ÇÑ´Ù. Á÷¾÷ ÀÚüÀÇ ¿øÀο¡ ÀÇÇÏ¿© ÀϾ´Â Áúº´¿¡´Â Á÷¾÷º´ ¿Ü¿¡, ÀçÇØ¼º ÁúȯÀÌ ÀÖ´Ù. ÀçÇØ¼º Áúȯµµ Á÷¾÷¿¡ Á¾»çÇϰí ÀÖ´Â ¸ðµç »ç¶÷¿¡°Ô ÀϾÁö¸¸, À¯µ¶ °¡½º³ª °í¿­¹°ÀÇ Æø¹ßÀÌ µ¹¹ßÀûÀ¸·Î ÀϾ´Â °Í°ú °°ÀÌ ¿ì¹ßÀûÀÎ »ç°íÀ̰ųª °ú½ÇÀ̹ǷΠÁ÷¾÷º´°ú´Â ±¸º°ÇÏ¿© »ý°¢Çϰí ÀÖ´Ù. Á÷¾÷º´Àº Á÷Àå Æ¯À¯ÀÇ º´À̱⠶§¹®¿¡ ¹ß»ý ¹æÁö¸¦ À§ÇÏ¿© ±× ¹ß»ý ¿øÀÎÀ» ±Ô¸íÇϰí, ȯ°æÀÇ °³¼± µî¿¡ ¿¹¹æ ´ëÃ¥À» ¼¼¿ìÁö ¾ÊÀ¸¸é ¾È µÈ´Ù. 2. Á÷¾÷¿¡ ¼ö¹ÝÇÏ´Â ÀÎÀÚ¿¡ ÀÇÇÑ Áúȯ, Áï ¿©·¯ °¡Áö ÇüÀÇ ÁøÆóÁõÀ̳ª ÇǺο° µîÀÌ ÀÖ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 17
anti-glomerular basement membrane disease Glomerulonephritis, usually of a generalised proliferative crescent-forming histologic type with a rapidly progressive course, marked by circulating anti-gbm antibodies and linear deposits of immunoglobulin and complement along the glomerular basement membrane. When associated with pulmonary haemorrhage the condition is called goodpasture syndrome.
(12 Dec 1998)
aortoiliac occlusive disease Obstruction of the abdominal aorta and its main branches by atherosclerosis.
(05 Mar 2000)
apical interstitial lung disease <radiology> A radiological diagnosis where fibrosis is seen in the apices (upper sections) of the lungs.
Likely causes include: cystic fibrosis, ankylosing spondylitis, sarcoidosis, silicosis, eosinophlic granuloma, TB and fungus, particularly aspergillus infection.
(25 Jun 1999)
Aran-Duchenne disease A serious neurologic disease that results from the progressive degeneration of the motor neurons.
(27 Sep 1997)
asbestos lung disease <radiology> Pleural plaques, earliest finding, may be only evidence, parietal pleura, 15-20 yrs after exposure, calcified after ca. 30 yrs, asbestosis, interstitial lung disease, perihilar regions to lung bases, shaggy heart, no cavitation or progressive massive fibrosis as in silicosis, crocidolite (blue) form most carcinogenic, associated with: malignant pleural mesothelioma, peritoneal mesothelioma, GI-tract malignancy
(12 Dec 1998)
asherman disease <radiology> Uterine synechiae, linear, lucent defects in uterus on HSG, usually secondary to endometrial trauma (D&C, etc.)
(12 Dec 1998)
atherosclerotic vascular disease <cardiology> The progressive narrowing and hardening of the arteries over time. This is known to occur to some degree with aging, but other risk factors that accelerate this process have been identified.
These factors include: high cholesterol, high blood pressure, smoking, diabetes and family history for atherosclerotic disease.
(27 Sep 1997)
Aujeszky's disease A highly contagious herpes virus infection affecting the central nervous system of swine, cattle, dogs, cats, rats, and other animals.
(12 Dec 1998)
Aujeszky's disease virus A herpesvirus causing pseudorabies in swine.
Synonym: Aujeszky's disease virus.
(05 Mar 2000)
Australian X disease A severe encephalitis with a high mortality rate occurring in the Murray Valley of Australia; the disease is most severe in children and is characterised by headache, fever, malaise, drowsiness or convulsions, and rigidity of the neck; extensive brain damage may result; it is caused by the Murray Valley encephalitis virus (genus Flavivirus).
Synonym: Australian X disease, Australian X encephalitis.
(05 Mar 2000)
Australian X disease virus A group B arbovirus of the genus Flavivirus that causes Murray Valley encephalitis; it is transmitted by Culex mosquitoes, and also infects birds and horses.
Synonym: Australian X disease virus, MVE virus.
(05 Mar 2000)
autoimmune disease <disease> A disease process that involves the production of host antibodies to host tissue.
(27 Sep 1997)
aviator's disease Syndrome resembling decompression sickness occurring in occupants of airplanes that reach very high altitudes without adequate pressurization of the cabin.
See: decompression sickness.
(05 Mar 2000)
Ayerza's disease <syndrome> Sclerosis of the pulmonary arteries in chronic cor pulmonale; associated with severe cyanosis, it is a condition resembling polycythemia vera but resulting from primary pulmonary arteriosclerosis or primary pulmonary hypertension and characterised by plexiform lesions of arterioles.
Synonym: Ayerza's disease, cardiopathia nigra, plexogenic pulmonary arteriopathy.
(05 Mar 2000)
Azorean disease A rare form of hereditary ataxia, characterised by onset in early adult life of progressive, spinocerebellar and extrapyramidal disease with external ophthalmoplegia, rigidity dystonia symptoms, and, often, peripheral amyotrophy; found predominantly in people of Azorean ancestry; autosomal dominant inheritance.
Synonym: Azorean disease, Portuguese-Azorean disease.
Origin: Surnames of two families studied in major descriptions of the disease.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 17
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 17
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 17
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 17
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 17
ÅëÇÕ°Ë»ö ¿Ï·á